1. Home
  2. BNTC vs RMNI Comparison

BNTC vs RMNI Comparison

Compare BNTC & RMNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • RMNI
  • Stock Information
  • Founded
  • BNTC 1995
  • RMNI 2005
  • Country
  • BNTC United States
  • RMNI United States
  • Employees
  • BNTC 16
  • RMNI N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • RMNI Business Services
  • Sector
  • BNTC Health Care
  • RMNI Consumer Discretionary
  • Exchange
  • BNTC Nasdaq
  • RMNI Nasdaq
  • Market Cap
  • BNTC 322.6M
  • RMNI 368.8M
  • IPO Year
  • BNTC N/A
  • RMNI N/A
  • Fundamental
  • Price
  • BNTC $13.75
  • RMNI $3.12
  • Analyst Decision
  • BNTC Strong Buy
  • RMNI Buy
  • Analyst Count
  • BNTC 7
  • RMNI 2
  • Target Price
  • BNTC $24.71
  • RMNI $6.00
  • AVG Volume (30 Days)
  • BNTC 64.1K
  • RMNI 267.9K
  • Earning Date
  • BNTC 05-12-2025
  • RMNI 05-01-2025
  • Dividend Yield
  • BNTC N/A
  • RMNI N/A
  • EPS Growth
  • BNTC N/A
  • RMNI N/A
  • EPS
  • BNTC N/A
  • RMNI N/A
  • Revenue
  • BNTC N/A
  • RMNI $428,753,000.00
  • Revenue This Year
  • BNTC N/A
  • RMNI $0.74
  • Revenue Next Year
  • BNTC N/A
  • RMNI $4.46
  • P/E Ratio
  • BNTC N/A
  • RMNI N/A
  • Revenue Growth
  • BNTC N/A
  • RMNI N/A
  • 52 Week Low
  • BNTC $5.08
  • RMNI $1.53
  • 52 Week High
  • BNTC $16.90
  • RMNI $4.15
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 55.16
  • RMNI 37.05
  • Support Level
  • BNTC $13.26
  • RMNI $3.18
  • Resistance Level
  • BNTC $14.22
  • RMNI $3.36
  • Average True Range (ATR)
  • BNTC 1.37
  • RMNI 0.21
  • MACD
  • BNTC 0.08
  • RMNI -0.04
  • Stochastic Oscillator
  • BNTC 87.27
  • RMNI 40.74

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About RMNI Rimini Street Inc. (DE)

Rimini Street Inc and its subsidiaries are providers of end-to-end enterprise software support, products, and services. The Company offers a comprehensive family of unified solutions to run, manage, support, customize, configure, connect, protect, monitor, and optimize clients' enterprise applications, database, and technology software platforms. The Company derives revenues from clients by providing subscription support services for enterprise resource planning, customer relationship management, product lifecycle management database, and technology software systems. Geographically, the company generates the majority of its revenue from the United States of America and the International market.

Share on Social Networks: